Press Releases

Press Releases

Selexis SA, a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, announced today that Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) has entered into a commercial license agreement for the use of Selexis’ technology and proprietary CHO-K1 cell line. Under the agreement, Progenics will have use…

Press Releases

IriSys LLC, the custom pharmaceutical development and manufacturing company, today announced that it has established a business development office in Shanghai. The office is staffed by Leonard Shi, Business Development Manager. Mr. Shi is an experienced pharmaceutical business development professional with a track record of success in China. IriSys was…

Press Releases

Kite Pharma, Inc., a clinical-stage biopharmaceutical company focused on developing engineered autologous T-cell therapy (eACT™) products for the treatment of cancer, today marked the official opening of its new commercial manufacturing facility in El Segundo, California. Over 300 employees, investors and company partners attended the unveiling of the 43,500-square-foot, state-of-the-art…

Press Releases

Several studies have linked the antipsychotic medication Abilify to the development of compulsive gambling in patients taking the drug, reports the national law firm of Baron & Budd. Patients on Abilify who have suffered economic losses due to gambling may be eligible to pursue legal action against the manufacturer. The…

Press Releases

Symic, a clinical stage biotherapeutics company developing multiple compounds that target and affect the extracellular matrix, today announced the appointment of Manish Anand as Vice President of Regulatory Affairs and Quality. Mr. Anand will lead the company's regulatory strategy, global filings and quality efforts. "Mr. Anand's wide range of experience…

Press Releases

Mallinckrodt Pharmaceuticals, a  leading global specialty biopharmaceutical company, today announced that it will purchase and donate more than 1 million Deterra™ drug deactivation pouches to help combat one of the top public health threats in the U.S. today – abuse of prescription pain medications. Through this initiative, families can actively…

Press Releases

Pfizer Inc. today broke ground for its new biologics clinical manufacturing facility in Andover, Massachusetts. Expanding the company’s presence in the state, Pfizer will invest more than $200 million in development of the 175,000 sq. ft. state-of-the-art facility that will enable the production of high-quality, complex biologics and vaccines. The…

Press Releases

Perrigo Company plc today announced it has received final U.S. Food and Drug Administration ("FDA") approval for the generic version of Mallinckrodt Pharmaceuticals' Ofirmev® (acetaminophen) injection 1000 mg/100 mL.   As previously announced, Perrigo can launch a generic version of Ofirmev® (acetaminophen) injection on December 6, 2020, or earlier under…

Press Releases

Zenith Epigenetics Corp. today announced that it has dosed the first patient in its Phase 1 clinical trial for ZEN-3694 in metastatic Castration Resistant Prostate Cancer ("mCRPC") patients. In the Phase 1 trial, Zenith will be evaluating the safety, pharmacokinetics, and efficacy of ZEN-3694 as a single agent and in…

Press Releases

Champions Oncology, Inc., or the "Company", a company engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs, today announced the closing of its previously announced underwritten public offering of 2,000,000 registered shares of its common stock, par value…